Baricitinib, an oral JAK inhibitor, is effective as treatment for moderate to severe atopic dermatitis when used in combination with topical steroids, a phase 3 randomised controlled trial has shown. Published in JAMA Dermatology, the international multicentre trial involved 329 adults with moderate to severe AD, treated at 68 centres including five clinics in Australia. ...
JAK inhibitor works well with topical corticosteroids in atopic dermatitis
By Michael Woodhead
2 Oct 2020